Multiple meta-analyses and systematic reviews have demonstrated that GLP-1 RAs can lead to substantial decreases in body weight and BMI, which are closely linked to reductions in OSA severity, as measured by the AHI (101–103). The gene discussed is GLP1R; the disease is obstructive sleep apnea syndrome.